Improved Graft Mesenchymal Stem Cell Survival in Ischemic Heart With a Hypoxia-Regulated Heme Oxygenase-1 Vector
- 4 October 2005
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 46 (7), 1339-1350
- https://doi.org/10.1016/j.jacc.2005.05.079
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemiaGene Therapy, 2005
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialThe Lancet, 2004
- Autologous bone-marrow stem-cell transplantation for myocardial regenerationThe Lancet, 2003
- Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseasesMethods, 2002
- Vigilant Vector: Heart-Specific Promoter in an Adeno-Associated Virus Vector for CardioprotectionHypertension, 2002
- Hypoxia inducible double plasmid system for myocardial ischemia gene therapy.Hypertension, 2002
- Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine HeartCirculation, 2002
- Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death StrategiesJournal of Molecular and Cellular Cardiology, 2001
- Bone marrow cells regenerate infarcted myocardiumNature, 2001
- Congestive heart failure: fifty years of progress.Circulation, 2000